Sort   by:  
 Page size 
ProteomicsNovel phenotypical and biochemical findings in mucolipidosis type II
Mucolipidosis type II (ML II) is a rare lysosomal storage disorder caused by deficiency of the UDP-GlcNAc:N-acetylglucosamine-1-phosphotransferase enzyme, which catalyzes the synthesis of the mannose-6-phosphate (M6P) targeting signal for lysosomal acid hydrolases. This deficiency hinders lysosomal ...
ORGANISM(S): Homo sapiens (Human) 
2025-05-07 | PXD060270 | Pride
Mucolipidosis ii-iii  early findings  biochemistry  biomarkers  proteomic studies  lysosomal diseases. 
ProteomicsMultiplexed quantitative proteomics in an autoimmune mice model of myocarditis (EAM)
We performed a high-throughput, multiplexed quantitative proteomics analysis to determine protein abundance changes produced by BML-111 treatment in EAM and Ctrl mice. EAM was induced in 7 weeks-old BALB/c female mice by immunization at days 0 and 7 with a subcutaneous injection of 350 μg of murine ...
ORGANISM(S): Mus musculus (Mouse) 
2022-12-07 | PXD024345 | Pride
Heart Mouse Lc-ms/ms 
UnknownMuscle regeneration in gilthead sea bream: Implications of endocrine and local regulatory factors and the crosstalk with bone.
Not available
S-EPMC9899866 | biostudies-literature
UnknownMyomaker and Myomixer Characterization in Gilthead Sea Bream under Different Myogenesis Conditions.
Not available
S-EPMC9737248 | biostudies-literature
UnknownComparison of Nine Early Warning Scores for Identification of Short-Term Mortality in Acute Neurological Disease in Emergency Department.
Not available
S-EPMC9024907 | biostudies-literature
UnknownExtracting relevant predictive variables for COVID-19 severity prognosis: An exhaustive comparison of feature selection techniques.
Not available
S-EPMC10101453 | biostudies-literature
UnknownSpecialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation.
Not available
S-EPMC9270570 | biostudies-literature
UnknownN-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study.
Not available
S-EPMC9150910 | biostudies-literature
UnknownVaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Not available
S-EPMC10668259 | biostudies-literature
UnknownDifferential clinical characteristics and prognosis of intraventricular conduction defects in patients with chronic heart failure.
Not available
S-EPMC3721573 | biostudies-literature
Sort   by:  
 Page size